Comparison of N-[C-11]methyl-norchloroepibatidine and N-[C-11]methyl-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane with N-[C-11]methyl-epibatidine in small animal PET studies

Citation
Je. Spang et al., Comparison of N-[C-11]methyl-norchloroepibatidine and N-[C-11]methyl-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane with N-[C-11]methyl-epibatidine in small animal PET studies, NUCL MED BI, 27(3), 2000, pp. 239-247
Citations number
52
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
27
Issue
3
Year of publication
2000
Pages
239 - 247
Database
ISI
SICI code
0969-8051(200004)27:3<239:CONAN>2.0.ZU;2-J
Abstract
Structural variations of the nicotinic acetylcholine receptor radioligand N -[C-11]methylepibatidine were made to form C-11-labeled N-methyl-norchloroe pibatidine (N-methyl-NorchloroEPB) and N-methyl-2-(2-pyridyl)-7-azabicyclo[ 2.2.1]heptane (N-methyl-2PABH). Radiosyntheses were performed by methylatio n with high radiochemical purities (>98%) and with specific activities betw een 140 and 500 GBq/mu mol at the end of synthesis. The radiochemical yield (decay-corrected, related to [C-11]CH3T) was between 5 and 10%. Positively and negatively radiolabeled enantiomers were prepared in high optical puri ty (>98%ee) by labeling of the appropriate optically active substrates, whi ch were obtained via chiral high performance liquid chromatography. For in vivo studies radioligands were administered intravenously in rats. Brain up take curves were acquired and combined with blocking experiments. Brain upt ake of N-[C-11]methyl-NorchloroEPB was similar to that of N-[C-11]methyl-EP B whereas N-[C-11]methyl-2PABH with the modified pyridine ring had a signif icantly lower uptake. NUCL MED BIOL 27;3:239-247, 2000. (C) 2000 Elsevier S cience Inc. All rights reserved.